Pancreatic Cancer Research

ResearcherUniversity of LouisvilleNo recent work listed

Matthew R. Woeste

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5594-2888; OpenAlex author ID A5071184036. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 1 paper

Papers 3

  1. Irreversible electroporation augments β-glucan induced trained innate immunity for the treatment of pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/jitc-2022-006221↗
  2. The induction of peripheral trained immunity in the pancreas incites anti-tumor activity to control pancreatic cancer progression. Co-author DOI 10.1038/s41467-022-28407-4↗
  3. Optimizing Patient Selection for Irreversible Electroporation of Locally Advanced Pancreatic Cancer: Analyses of Survival. Co-author DOI 10.3389/fonc.2021.817220↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Robert C.G. Martin · 3 shared papers, 2021–2023 · strength 0.42
  2. Robert A Mitchell · 2 shared papers, 2022–2023 · strength 0.28
  3. Chuanlin Ding · 2 shared papers, 2022–2023 · strength 0.28
  4. Anne E. Geller · 2 shared papers, 2022–2023 · strength 0.28
  5. Jun Yan · 2 shared papers, 2022–2023 · strength 0.28
  6. Yan Li · 1 shared paper, 2023 · strength 0.15
  7. John D. Christein · 1 shared paper, 2021 · strength 0.15
  8. Matthew John Weiss · 1 shared paper, 2021 · strength 0.15
  9. Rebekah Ruth White · 1 shared paper, 2021 · strength 0.15
  10. Haixun Guo · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.